Thr124Met myelin protein zero mutation mimicking motor neuron disease

References

• Shy ME, Jáni A, Krajewski K, Grandis M, Lewis RA, Li J, et al. Phenotypic clustering in MPZ mutations. Brain. 2004;127:371–84.
   PubMed Web of Science ®Google Scholar
• Callegari I, Gemelli C, Geroldi A, Veneri F, Mandich P, D'Antonio M, et al. Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype. J Neurol. 2019;266:2629–45.
   PubMed Web of Science ®Google Scholar
• Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry. 1999;66:779–82.
   PubMed Web of Science ®Google Scholar
• De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Löfgren A, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain. 1999;122:281–90.
   PubMed Web of Science ®Google Scholar
• Misu K, Yoshihara T, Shikama Y, Awaki E, Yamamoto M, Hattori N, et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry. 2000;69:806–11.
   PubMed Web of Science ®Google Scholar
• Hanemann CO, Gabreëls-Festen AA, De Jonghe P. Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul Disord. 2001;11:753–6.
   PubMed Web of Science ®Google Scholar
• Stojkovic T, de Seze J, Dubourg O, Arne-Bes MC, Tardieu S, Hache JC, et al. Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin Neurophysiol. 2003;114:1609–14.
   PubMed Web of Science ®Google Scholar
• Kurihara S, Adachi Y, Imai C, Araki H, Hattori N, Numakura C, et al. Charcot-Marie-Tooth families in Japan with MPZ Thr124Met mutation. J Neurol Neurosurg Psychiatry. 2004;75:1492–4.
   PubMed Web of Science ®Google Scholar
• Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain. 2003;126:134–51.
   PubMed Web of Science ®Google Scholar
• Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F, et al. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene . Neurology 1998;50:1397–401.
   PubMed Web of Science ®Google Scholar
• Beirowski B, Babetto E, Wrabetz L. Axon degeneration: linking axonal bioenergetics to myelin. J Cell Biol. 2016;215:437–40.
   PubMed Web of Science ®Google Scholar
• Nave KA, Trapp BD. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci. 2008;31:535–61.
   PubMed Web of Science ®Google Scholar
• Senderek J, Hermanns B, Hartmann C, et al. P0 point mutations in Charcot-Marie-Tooth neuropathy type 2: two novel amino acid substitutions (Tyr119Cys; Asp61Gly) and a possible hot spot on Thr124Met. J Peripher Nerv Syst 1999;4:301–2.
   Google Scholar
• Rajabally YA, Abbott RJ. Charcot-Marie-Tooth disease due to the Thr124Met mutation in the myelin protein zero gene associated with multiple sclerosis. J Peripher Nerv Syst. 2005;10:388–9.
   PubMed Web of Science ®Google Scholar
• Breza M, Koutsis G. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J Neurol. 2019;266:565–73.
   PubMed Web of Science ®Google Scholar
• Ishiura H, Sako W, Yoshida M, Kawarai T, Tanabe O, Goto J, et al. The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet. 2012;91:320–9.
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Kohno Y, Nissato S, Shoji S. Compound heterozygosity with two novel mutations in the HEXB gene produces adult Sandhoff disease presenting as a motor neuron disease phenotype. J Neurol Sci. 2002;195:129–38.
   PubMed Web of Science ®Google Scholar
• Hellmann MA, Kakhlon O, Landau EH, Sadeh M, Giladi N, Schlesinger I, et al. Frequent misdiagnosis of adult polyglucosan body disease. J Neurol. 2015;262:2346–51.
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Quaranta L, Madia F, Lippi G, Conte A, Lo Monaco M, et al. Peripheral neuropathy with hypomyelinating features in adult-onset Krabbe's disease. Neuromuscul Disord 2002;12:386–91.
   PubMed Web of Science ®Google Scholar
• Luigetti M, Pizzuti A, Bartoletti S, Houlden H, Pirro C, Bottillo I, et al. Triple A syndrome: a novel compound heterozygous mutation in the AAAS gene in an Italian patient without adrenal insufficiency. J Neurol Sci. 2010;290:150–2.
   PubMed Web of Science ®Google Scholar
• Musacchio T, Zaum A-K, Üçeyler N, Sommer C, Pfeifroth N, Reiners K, et al. ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. J Neurol. 2017;264:11–20.
   PubMed Web of Science ®Google Scholar
• Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol. 2017;30:513–20.
   PubMed Web of Science ®Google Scholar
• Weiss MD, Oakley JC, Meekins GD. Hypoglossal neuropathy in Lewis-Sumner syndrome masquerading as motor neuron disease. Neurology 2006;67:175–6.
   PubMed Web of Science ®Google Scholar
• Goyal NA, Mozaffar T. Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: an ALS mimicker. Neurol Genet. 2015;1:e18.
   PubMed Web of Science ®Google Scholar
• Lozeron P, Lacroix C, Theaudin M, Richer A, Gugenheim M, Adams D, et al. An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation. Amyloid. 2013;20:188–92.
   PubMed Web of Science ®Google Scholar
• Quattrini A, Nemni R, Sferrazza B, Ricevuti G, Dell'Antonio G, Lazzerini A, et al. Amyloid neuropathy simulating lower motor neuron disease. Neurology 1998;51:600–2.
   PubMed Web of Science ®Google Scholar
• Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M, Johnsen B, Fawcett PRW, Labarre-Vila A, et al. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry. 2007;78:746–9.
   PubMed Web of Science ®Google Scholar
• Isaacs JD, Dean AF, Shaw CE, Al-Chalabi A, Mills KR, Leigh PN, et al. Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder? J Neurol Neurosurg Psychiatry. 2007;78:750–3.
   PubMed Web of Science ®Google Scholar
• Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 2007;69:2236–42.
   PubMed Web of Science ®Google Scholar
• Gentile F, Scarlino S, Falzone YM, Lunetta C, Tremolizzo L, Quattrini A, et al. The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research. Front Neurosci. 2019;13:601.
   PubMed Web of Science ®Google Scholar
• Marchesi C, Ciano C, Salsano E, Nanetti L, Milani M, Gellera C, et al. Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene. Neuromuscul Disord. 2011;21:129–31.
   PubMed Web of Science ®Google Scholar
• Canali E, Chiari A, Sola P, Fioravanti V, Valzania F, Pentore R, et al. Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies. Amyotroph Lateral Scler. 2010;11:335–6.
   PubMed Web of Science ®Google Scholar
• Tao QQ, Wei Q, Wu ZY. Sensory nerve disturbance in amyotrophic lateral sclerosis. Life Sci. 2018;203:242–5.
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, Lattante S, et al. New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis. Brain Pathol. 2016;26:266–75.
   PubMed Web of Science ®Google Scholar
• Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, Shiga K, et al. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 2007;448:68–72.
   PubMed Web of Science ®Google Scholar
• Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet. 2009;84:85–8.
   PubMed Web of Science ®Google Scholar
• Liu Y-T, Laurá M, Hersheson J, Horga A, Jaunmuktane Z, Brandner S, et al. Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy. Neurology 2014;83:612–9.
   PubMed Web of Science ®Google Scholar
• Nicolas A, Kenna KP, Renton AE, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 2018;97:1268–83.e6.
   PubMed Web of Science ®Google Scholar
• Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet. 1994;3:1757–61.
   PubMed Web of Science ®Google Scholar
• Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain. 2003;126:590–7.
   PubMed Web of Science ®Google Scholar
• Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591–8.
   PubMed Web of Science ®Google Scholar
• Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, et al. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. Brain. 2016;139:73–85.
   PubMed Web of Science ®Google Scholar
• Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010;68:857–64.
   PubMed Web of Science ®Google Scholar
• Gonzalez MA, Feely SM, Speziani F, Strickland AV, Danzi M, Bacon C, et al. A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain. 2014;137:2897–902.
   PubMed Web of Science ®Google Scholar
• Gite J, Milko E, Brady L, Baker SK. Phenotypic convergence in Charcot-Marie-Tooth 2Y with novel VCP mutation. Neuromuscul Disord. 2020;30:232–5.
   PubMed Web of Science ®Google Scholar
• Goldstein O, Kedmi M, Gana-Weisz M, Twito S, Nefussy B, Vainer B, et al. Rare homozygosity in amyotrophic lateral sclerosis suggests the contribution of recessive variants to disease genetics. J Neurol Sci. 2019;402:62–8.
   PubMed Web of Science ®Google Scholar
• Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36:449–51.
   PubMed Web of Science ®Google Scholar
• Katz M, Davis M, Garton FC, Henderson R, Bharti V, Wray N, et al. Mutations in heat shock protein beta-1 (HSPB1) are associated with a range of clinical phenotypes related to different patterns of motor neuron dysfunction: a case series. J Neurol Sci. 2020;413:116809.
   PubMed Web of Science ®Google Scholar
• Osmanovic A, Rangnau I, Kosfeld A, Abdulla S, Janssen C, Auber B, et al. FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study. Eur J Hum Genet. 2017;25:324–31.
   PubMed Web of Science ®Google Scholar